A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Giuseppe Campiani, Cosima T. Baldari et al.|Biomedicine & Pharmacotherapy|2024Cited by 9